Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02JXG
|
||||
Former ID |
DCL000975
|
||||
Drug Name |
SB-265610
|
||||
Drug Type |
Small molecular drug
|
||||
Company |
GlaxoSmithKline
|
||||
Structure |
Download2D MOL |
||||
Formula |
C14H9BrN6O
|
||||
Canonical SMILES |
C1=CC=C(C(=C1)NC(=O)NC2=CC=C(C3=NNN=C23)C#N)Br
|
||||
InChI |
1S/C14H9BrN6O/c15-9-3-1-2-4-10(9)17-14(22)18-11-6-5-8(7-16)12-13(11)20-21-19-12/h1-6H,(H2,17,18,22)(H,19,20,21)
|
||||
InChIKey |
SEDUMQWZEOMXSO-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 211096-49-0
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | High affinity interleukin-8 receptor B | Target Info | Antagonist | [536223] | |
NetPath Pathway | TNFalpha Signaling Pathway | ||||
Pathway Interaction Database | IL8- and CXCR2-mediated signaling events | ||||
References | |||||
Ref 531406 | SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans. Br J Clin Pharmacol. 2011 Aug;72(2):282-93. | ||||
Ref 536223 | Emerging drugs for the treatment of chronic obstructive pulmonary disease. Expert Opin Emerg Drugs. 2006 May;11(2):275-91. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.